B. Phillips

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

D. Salinger, F. Appelbaum, P. Vicini, 2009, Clinical pharmacology and therapeutics.

Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.

R. Al-Sarraf, K. Rassnick, J. Chretin, 2010, Veterinary and comparative oncology.

A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma

L. Puls, D. Griffin, C. Schammel, 2010, Medical oncology.

A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma

L. Puls, D. Griffin, C. Schammel, 2010, Medical oncology.